Skye Bioscience, Inc.

Q4 2024 13F Holders

Symbol
SKYE
CUSIP
83086J200
Type
Equity
Class
COM NEW
Num filings
75
Total reported value, excl. options
$71.3 M
Manager Report Date Value ($000) Shares Option Type